For: |
Chen SJ, Wang LJ, Zhu Q, Cai JT, Chen T, Si JM. Effect of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i12/1914.htm |
Number | Citing Articles |
1 |
Fady Maher Wadea. Insights to Indications and Harm of Proton Pump Inhibitors Usage in Patients with Liver Cirrhosis. Gastroenterology & Hepatology: Open Access 2017; 7(5) doi: 10.15406/ghoa.2017.07.00250
|
2 |
Barry J. Marshall, Helen M. Windsor, Kazufumi Kimura. Practical Gastroenterology and Hepatology: Esophagus and Stomach. 2010; : 336 doi: 10.1002/9781444327311.ch44
|
3 |
Lynn Marie Trotti, Prabhjyot Saini, Amanda A Freeman, Donald L Bliwise, Paul S García, Andrew Jenkins, David B Rye. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience. Journal of Psychopharmacology 2014; 28(7): 697 doi: 10.1177/0269881113515062
|
4 |
O. Y. Lukivskaya, E. B. Belonovskaya, E. E. Naruta, I. A. Kuzmitskaya, S. N. Kirko, V. U. Buko. S-ADENOSYLMETHIONINE IN THE TREATMENT OF EXPERIMENTAL HEPATIC ENCEPHALOPATHY. Hepatology and Gastroenterology 2019; 3(2): 166 doi: 10.25298/2616-5546-2019-3-2-166-171
|
5 |
Junwei Li, Hongwei Yu, Yuexia Wang, Bin Wang, Rongguang Zhang, Shuaiyin Chen, Guangcai Duan. A meta-analysis of the association betweenHelicobacter pyloriinfection and risk of hepatic encephalopathy. Journal of Public Health 2023; 45(2): 321 doi: 10.1093/pubmed/fdac078
|
6 |
German Soriano, Eva Román, Joan Córdoba. Cognitive dysfunction, falls and helicobacter pylori in cirrhosis. Hepatology 2013; 57(3): 1285 doi: 10.1002/hep.25922
|
7 |
Huck‐Joo TAN, Khean‐Lee GOH. Extragastrointestinal manifestations of Helicobacter pylori infection: Facts or myth? A critical review. Journal of Digestive Diseases 2012; 13(7): 342 doi: 10.1111/j.1751-2980.2012.00599.x
|
8 |
Fernando Gomes Romeiro, Fabio da Silva Yamashiro, Madileine Francely Américo, Luciana Aparecida Corá, Giovanni Faria Silva, JoséRicardodeArruda Miranda, Carlos Antonio Caramori. Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-13
|
9 |
Liliana Rivera-Espinosa, Esaú Floriano-Sánchez, José Pedraza-Chaverrí, Elvia Coballase-Urrutia, Aristides Sampieri, Daniel Ortega-Cuellar, Noemí Cárdenas-Rodríguez, Liliana Carmona-Aparicio. Contributions of Microdialysis to New Alternative Therapeutics for Hepatic Encephalopathy. International Journal of Molecular Sciences 2013; 14(8): 16184 doi: 10.3390/ijms140816184
|
10 |
Shefali Amin, Biraj Shrestha, Ameya Deshmukh, Manish Shrestha, Parth Desai, John Altomare. Helicobacter pylori Infection and Complications of Cirrhosis. Cureus 2024; doi: 10.7759/cureus.54419
|
11 |
Seham S. El-seid, Fatma A. Attia, Mona Abd El-Raouf, Ghada S. Abd Al-Azeem, Nagwa Abd EL-Ghaffar Mohammed, Heba Anwar. The role of Helicobacter pylori in minimal hepatic encephalopathy. The Egyptian Journal of Internal Medicine 2015; 27(1): 26 doi: 10.4103/1110-7782.155849
|
12 |
Bang-Li Hu, Hong-Yu Wang, Guang-Ye Yang. Association of Helicobacter pylori infection with hepatic encephalopathy risk: A systematic review. Clinics and Research in Hepatology and Gastroenterology 2013; 37(6): 619 doi: 10.1016/j.clinre.2013.05.004
|
13 |
Celia Regina Carlini, Deiber Olivera-Severo, Rodrigo Ligabue-Braun. Ureases. 2024; : 47 doi: 10.1016/B978-0-323-91800-8.00014-X
|
14 |
Tsung-Hsing Hung, Hsing-Feng Lee, Chih-Wei Tseng, Chih-Chun Tsai, Chen-Chi Tsai. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding. Clinics and Research in Hepatology and Gastroenterology 2018; 42(4): 353 doi: 10.1016/j.clinre.2017.11.011
|
15 |
Meghan K. Harris, Debra Elliott, Robert N. Schwendimann, Alireza Minagar, Stephen L. Jaffe. Neurologic Presentations of Hepatic Disease. Neurologic Clinics 2010; 28(1): 89 doi: 10.1016/j.ncl.2009.09.016
|
16 |
Jannis Kountouras. A glimpse into Helicobacter pylori involvement in hepatic encephalopathy. Arab Journal of Gastroenterology 2025; 26(1): 141 doi: 10.1016/j.ajg.2025.01.005
|
17 |
Peter Nagy, Saga Johansson, Michael Molloy-Bland. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathogens 2016; 8(1) doi: 10.1186/s13099-016-0091-7
|
18 |
Michael Bismuth, Natalie Funakoshi, Jean-François Cadranel, Pierre Blanc. Hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2011; 23(1): 8 doi: 10.1097/MEG.0b013e3283417567
|
19 |
Tanzeela Yasmin Khalid, Ben De Lacy Costello, Richard Ewen, Paul White, Simon Stevens, Fiona Gordon, Peter Collins, Anne McCune, Achuth Shenoy, Sharan Shetty, Norman Mark Ratcliffe, Chris Simon Probert. Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: a pilot study. Metabolomics 2013; 9(5): 938 doi: 10.1007/s11306-013-0510-4
|
20 |
Parth J. Parekh, Luis A. Balart. Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy. Clinics in Liver Disease 2015; 19(3): 529 doi: 10.1016/j.cld.2015.05.002
|
21 |
Joanna Pogorzelska, Magda Łapińska, Alicja Kalinowska, Tadeusz W. Łapiński, Robert Flisiak. Helicobacter pylori infection among patients with liver cirrhosis. European Journal of Gastroenterology & Hepatology 2017; 29(10): 1161 doi: 10.1097/MEG.0000000000000928
|
22 |
Hai-Xing Jiang, Shan-Yu Qin, Zhi-gang Min, Ming-Zhi Xie, Tao Lin, Bang-Li Hu, Xiao-Yun Guo. Association ofHelicobacter pyloriwith Elevated Blood Ammonia Levels in Cirrhotic Patients: A Meta-Analysis. Yonsei Medical Journal 2013; 54(4): 832 doi: 10.3349/ymj.2013.54.4.832
|